Coca-Cola vs Exxon: Which Blue Chip Won the Decade?
As 2025 winds down, Coca-Cola and Exxon Mobil stand as twin blue chips with very different stories. One fuels steady ...
What Is Sequence Of Returns Risk In Retirement
This piece explains what sequence of returns risk is in retirement, why it matters for retirement income, and how to interpret its effects on portfolios.
26,990 articles
Former Trump Advisor: ‘Conservatives’ Threaten R&D Boom
A new policy debate threatens to tax the income universities earn from licensing taxpayer-funded research, potentiall...
Investors Left $348 Table: Fees Weigh on Gold Miners ETFs in 2026
Over the past year, the more expensive GDX underperformed cheaper peers, costing investors tens of dollars per thousa...
AppLovin Price Prediction Raised After Earnings Beat
AppLovin rode a stronger-than-expected Q1 to lift expectations for its AI-focused ad platform. Margin gains and robus...
Yield From Russell 2000? Covered-Call Fund Bets Big Tech
A new covered-call ETF chasing a fat income stream uses the Russell 2000 as its base. This piece explains the mechani...
Protecting Yourself From Regulator Imposter Scams Today
Scammers pretending to be regulators are getting more convincing. This guide helps you spot the red flags, verify leg...
Grayscale Setting Quarterly Cash From ETH and SOL Staking
Grayscale is moving to turn staking rewards from its Ethereum and Solana staking ETFs into cash payouts on a quarterl...
Big AI Spenders Poised to Actually Payoff Sooner Than Later
Meta Platforms and Microsoft are turning large AI investments into monetizable products and services, hinting at prof...
I’m Buying Apple’s AI Advantage as Investors Eye the Edge
Apple is leaning into a capital-light AI model that runs on-device and with trusted partners. This story explains why...
Nvidia Spending Cash Right? Investors Await Update
Nvidia is set to outline how it will deploy its cash as AI demand drives growth. The company still pays a token divid...
Forget Palantir: Unstoppable AI Stocks to Buy Right Now
As Palantir hype cools, two AI-driven cash-flow engines emerge as steadier bets. This report explains why Alphabet an...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status